avaliação da resistência insulínica na síndrome de turner ...

More documents

Recommendations

Info

33. El Abd S, Patton MA, Turk J, Hoey H, Howlin P. Social, communicational, and behavioral deficits associated with ring X turner syndrome. Am J Med Genet 1999; 88:510-6. 34. Gøtzsche CO, Krag-Olsen B, Nielsen J, Sorensen KE, Kristensen BO. Prevalence of cardiovascular malformations and association with karyotypes in Turner’s syndrome. Arch Dis Child 1994; 71:433–436. 35. Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics 1998; 101:E11. 36. Lin AE, Lippe B, Rosenfeld R. Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics 1998; 102:E12. 37. Mazzanti L, Cacciari E, Italian Study Group for Turner Syndrome. Congenital heart disease in patients with Turner syndrome. J Pediatr 1998; 133:688–692. 38. Gravholt CH. Epidemiological, endocrine and metabolic features in Turner syndrome. Arq Bras Endocrinol Metabol 2005; 49:145-56. 39. Gravholt CH, Naeraa RW, Nyholm B, Gerdes LU, Christiansen E, Schmitz O, et al. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care 1998; 21:1062-70. 40. Radetti G, Mazzanti L, Paganini C, Bernasconi S, Russo G, Rigon F, Cacciari E. Frequency, clinical and laboratory features of thyroiditis in girls with Turner’s syndrome. Acta Paediatr 1995; 84:909-912. 41. American Association of Clinical Endocrinologists Growth Hormone Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children - 2003 update. Endocr Pract 2003; 9:64-76 42. Consensus Development Conference on Insulin Resistance. 5-6 November 1997. American Diabetes Association. Diabetes Care 1998; 21:310-4. 60 60
43. Cesaretti ML, Kohlmann Junior O. Experimental models of insulin resistance and obesity: lessons learned. Arq Bras Endocrinol Metabol 2006; 50:190-7. 44. I Diretriz brasileira de diagnóstico e tratamento da síndrome metabólica. Arq Bras Cardiol 2005; 84(1):1-28. 45. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications; Part 1: diagnosis and classification of diabetes mellitus. Department of Non Communicable Disease Surveillance, WHO, Genebra 1999. 46. National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Progeam (NCEP) of high blood cholesterol in adults (adult treatment panel III). J Am Med Assoc 2001; 285: 2486- 2497. 47. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Bruxelas, Bélgica, 2006. 48. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocrine Rev 1985; 6:45-85. 49. Yalow RS, Berson SA. Immunoassay of endogenous plasma insulin in men. 1960. Obes Res 1996;4:583-600. 50. Geloneze B, Tambascia MA. Avaliação laboratorial e diagnóstico da resistência insulínica. Arq Bras Endocrinol Metabol 2006; 50:208-15. 51. Bergman RN. Lilly lecture. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 1989; 38:1512-27. 52. Cobelli C, Pacini G, Toffolo G, Sacca L. Estimation of insulin sensitivity and glucose clearence from minimal model: New insights from labeled IVGTT. Am J Physiol 1986; 250:E591-8. 61 61
Page 1 and 2:
Universidade Federal do Rio de Jane
Page 3 and 4:
3 3
Page 5 and 6:
DEDICATÓRIA Ao Adilson, pelo amor
Page 7 and 8:
RESUMO AVALIAÇÃO DA RESISTÊNCIA
Page 9 and 10: SUMÁRIO 2007 1 - INTRODUÇÃO.....
Page 11 and 12: LISTA DE SIGLAS E ABREVIATURAS AMP
Page 13 and 14: Tabela 14 - Análise descritiva das
Page 15 and 16: 1 - INTRODUÇÃO A síndrome de Tur
Page 17 and 18: gonadal é suficientemente grave pa
Page 19 and 20: 2.2 - Resistência Insulínica - As
Page 21 and 22: Acredita-se que o HOMA seja uma alt
Page 23 and 24: 2.3 - Resistência Insulínica na s
Page 25 and 26: 2.4 - Baixo Peso ao Nascer e Altera
Page 27 and 28: Gale e cols. avaliaram homens e mul
Page 29 and 30: 4 - PACIENTES E MÉTODOS 4.1 - Casu
Page 31 and 32: As pacientes foram submetidas a pun
Page 33 and 34: 3.3.2 para análise dos dados. O cr
Page 35 and 36: A média do peso ao nascer na casu
Page 37 and 38: 5.2 - Avaliação do perfil clínic
Page 39 and 40: 5.3 - Avaliação do perfil clínic
Page 41 and 42: 5.4 - Avaliação do perfil laborat
Page 43 and 44: 65 272 p=0,0002 Figura 3 - Valores
Page 45 and 46: Tabela 12 - Análise estatística d
Page 47 and 48: =0,127; p=0,39 Figura 4 - Dispersã
Page 49 and 50: Percentil 90 2,33 HOMA-IR Figura 6
Page 51 and 52: 43 o mosaicismo poderia justificar
Page 53 and 54: de uso de GH nestas pacientes (9 no
Page 55 and 56: adequado. A etiopatogenia da RI na
Page 57 and 58: 8 - REFERÊNCIAS 1. Chromosome abno
Page 59: 20. Manuel M, Katayama PK, Jones HW
Page 63 and 64: 62. Rasio E, Antaki A, Van Campenho
Page 65 and 66: 85. Ibanez L, Jimenez R, de Zegher
Page 67: metabolism, circulating adipokines,
show all

avaliação da resistência insulínica na síndrome de turner ...

Create successful ePaper yourself

Delete template?

Save as template?